Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Growing the evidence base for medical cannabis

Shannon Lough
CMAJ September 22, 2015 187 (13) 955-956; DOI: https://doi.org/10.1503/cmaj.109-5129
Shannon Lough
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • Confounding placebo effects in medical marijuana research
    Natasha KJ Campbell
    Posted on: 02 May 2016
  • Posted on: (2 May 2016)
    Confounding placebo effects in medical marijuana research
    • Natasha KJ Campbell, Research Coordinator

    Research in the medical marijuana field is burgeoning as various governments consider changing policy in favour of legalizing the marijuana plant Cannabis sativa. Like any modern research effort, the "gold standard" for assessing a new treatment for efficacy compares the treatment to a placebo group. However, controlling for the placebo effects of marijuana may be extremely difficult and several confounds must be carefull...

    Show More

    Research in the medical marijuana field is burgeoning as various governments consider changing policy in favour of legalizing the marijuana plant Cannabis sativa. Like any modern research effort, the "gold standard" for assessing a new treatment for efficacy compares the treatment to a placebo group. However, controlling for the placebo effects of marijuana may be extremely difficult and several confounds must be carefully considered by researchers in this field.

    Broadly, the placebo effect is an improvement in health or behaviour which engulfs a biopsychosocial phenomenon attributable to the placebo and treatment context (1). On the psychosocial end of the placebo effect spectrum, "the meaning effect" is a similar notion that pertains to the meaning attached to the treatment, as well as the setting and the context surrounding the medical encounter (2). On the psychobiological end of the spectrum, researchers highlight the central role of expectation, suggestion, and conditioning in placebo-related phenomena (3). New treatments are compared to placebos because placebo effects are very strong - oftentimes stronger than the effects of the treatment in question.

    When it comes to marijuana, several placebo effects come into play. Marijuana has a distinct smell and taste, which may elicit classical conditioning responses. Placebo science research holds strong evidence for the effect of classical conditioning related to odour and taste: caffeine- associated stimuli like the smell and taste of coffee, for example, is shown to increase skin conductance responses and startle eyeblink reflexes in the absence of caffeine (4, 5). In addition, visual cues associated with smoking marijuana such as cigarettes, smoke, or lighters may elicit the placebo effect and still remain a factor in even the most well- controlled recent studies (6, 7).

    The method of marijuana administration and dose in new trials can carry powerful placebo effects. Will the marijuana be inhaled, injected, administered topically or sublingually? Placebo science demonstrates that placebo injections work better than placebo pills (8), and that four placebos work better than two (9). The strength of the effect of marijuana may differ greatly depending on the method of administration. To date, medical marijuana research spans several routes of administration including injections of the psychoactive ingredient delta-9- tetrahydrocannabinol (THC) (10), oral THC capsule (11) or spray (12), as well as smoking a marijuana pipe (7) or cigarette (6). These differing methods of administration will each carry their own placebo effects; grouping such findings together should be avoided.

    There is a way to overcome the interference between treatment and placebo effects of marijuana. We can take these lessons from placebo analgesia studies. Studies comparing hidden treatments (for example, using a computer controlled infusion machine that is pre-programmed to dispense medication at a desired time) with open administration (where medication is given overtly by a physician or nurse) can eliminate the placebo component by making the patient unaware that a medical therapy is being carried out. Patients in this study design do not know that the drug is being injected, therefore eliminating expectations of a therapeutic response. Indeed, a trial conducted by Benedetti et al. (13) showed that a CCK antagonist induced stronger analgesia than a placebo, suggesting that it was a good analgesic. However, this conclusion proved to be erroneous because a hidden injection of the same CCK antagonist was totally ineffective, showing that it had no intrinsic analgesic pharmacodynamic action, but instead, it enhanced placebo-activated release of endogenous opioids (14, 15). If similar studies are replicated with THC, researchers may be able to elucidate the pain relieving properties of marijuana's primary psychoactive ingredient.

    The marijuana research field is new. Standardized methods need to be developed so that researchers can properly evaluate the effectiveness of this treatment for various disorders. Controlling for the powerful placebo effects of marijuana will bring the scientific community one step closer to identifying which conditions this treatment may be most useful for, and how it is best administered.

    References

    1. Kirsch I. Hidden administration as ethical alternatives to the balanced placebo design. Prevention & Treatment. 2003;6(1).

    2. Moerman DE. Meaning, medicine, and the "placebo effect". Cambridge, U.K. ; New York: Cambridge University Press; 2002.

    3. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. The Journal of Neuroscience. 2003;23(10):4315-23.

    4. Flaten MA, Blumenthal TD. Caffeine-associated stimuli elicit conditioned responses: an experimental model of the placebo effect. Psychopharmacology. 1999;145(1):105-12.

    5. Mikalsen A, Bertelsen B, Flaten M. Effects of caffeine, caffeine- associated stimuli, and caffeine-related information on physiological and psychological arousal. Psychopharmacology. 2001;157(4):373-80.

    6. Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, et al. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. The Journal of Pain. 2008;9(6):506-21.

    7. Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. Canadian Medical Association Journal. 2010;182(14):E694-E701.

    8. Chaput De Saintonge DM, Herxheimer A. Harnessing placebo effects in health care. Lancet. 1994;344(8928):995-8.

    9. De Craen AJM, Moerman DE, Heisterkamp SH, Tytgat GNJ, Tijssen JGP, Kleijnen J. Placebo effect in the treatment of duodenal ulcer. British Journal of Clinical Pharmacology. 1999;48(6):853-60.

    10. D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry. 2005;57(6):594-608.

    11. Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ. 2004 2004-07-29 21:55:16;329(7460):253.

    12. Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65(6):812-9.

    13. Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. The Lancet. 1995;346(8984):1231.

    14. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta J-K. Neurobiological Mechanisms of the Placebo Effect. The Journal of Neuroscience. 2005 November 9, 2005;25(45):10390-402.

    15. Benedetti F, Maggi G, Lopiano L, Lanotte M, Rainero I, Vighetti S, et al. Open versus hidden medical treatments: The patient's knowledge about a therapy affects the therapy outcome. Prevention & Treatment. [Journal; Peer Reviewed Journal]. 2003 Jun;6(1).

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 187 (13)
CMAJ
Vol. 187, Issue 13
22 Sep 2015
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Growing the evidence base for medical cannabis
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Growing the evidence base for medical cannabis
Shannon Lough
CMAJ Sep 2015, 187 (13) 955-956; DOI: 10.1503/cmaj.109-5129

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Growing the evidence base for medical cannabis
Shannon Lough
CMAJ Sep 2015, 187 (13) 955-956; DOI: 10.1503/cmaj.109-5129
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Quebec’s registry
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Medical marijuana research
  • PubMed
  • Google Scholar

Cited By...

  • Medical marijuana research
  • Google Scholar

More in this TOC Section

  • Feds update immunization advice with Moderna vaccine approval
  • Canada will have three-digit suicide prevention hotline by 2023
  • Trudeau promises to boost federal health transfers when the pandemic is over
Show more News

Similar Articles

Collections

  • Topics
    • Research methods & statistics
    • Cannabis

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire